Invivyd, Inc.
- IVVD
- NASDAQ
- Biotechnology
- Antibody Therapies
- Infectious Disease
$0.62
Today +0.55%Quote Oct 19, 2026, 07:39 PM UTC
−17.10%over the last month
Max drawdown −39.2%From 1-month high −38.1%3 months −9.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Invivyd
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
122
Founded
2020
Market value
$183.3M
Quote Oct 19
Floor
$0.60
3.2% below price
Resistance
$0.64
3.4% above price
Price vs analyst targets
8 analysts
Lowest target
$9.00Highest target
$10.00
$9.00Highest target
$10.00
- Price $0.62
- Average target $9.50
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 1427% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about IVVDPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free